Zynex, Inc.

NasdaqGS:ZYXI Lagerbericht

Marktkapitalisierung: US$279.0m

Zynex Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Zynex is forecast to grow earnings and revenue by 45.8% and 17.5% per annum respectively while EPS is expected to grow by 46.1% per annum.

Wichtige Informationen

45.8%

Wachstumsrate der Gewinne

46.1%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum17.4%
Wachstumsrate der Einnahmen17.5%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert25 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Here's Why Analysts Just Lifted Their Zynex, Inc. (NASDAQ:ZYXI) Price Target To US$19.88

May 03
Earnings Update: Here's Why Analysts Just Lifted Their Zynex, Inc. (NASDAQ:ZYXI) Price Target To US$19.88

Recent updates

Zynex (NASDAQ:ZYXI) Seems To Use Debt Quite Sensibly

Oct 26
Zynex (NASDAQ:ZYXI) Seems To Use Debt Quite Sensibly

Zynex, Inc.: 2025 Looks Like A Brighter Year

Oct 09

With Zynex, Inc. (NASDAQ:ZYXI) It Looks Like You'll Get What You Pay For

Jul 31
With Zynex, Inc. (NASDAQ:ZYXI) It Looks Like You'll Get What You Pay For

Earnings Update: Here's Why Analysts Just Lifted Their Zynex, Inc. (NASDAQ:ZYXI) Price Target To US$19.88

May 03
Earnings Update: Here's Why Analysts Just Lifted Their Zynex, Inc. (NASDAQ:ZYXI) Price Target To US$19.88

Earnings Miss: Zynex, Inc. Missed EPS By 33% And Analysts Are Revising Their Forecasts

Mar 03
Earnings Miss: Zynex, Inc. Missed EPS By 33% And Analysts Are Revising Their Forecasts

Why Investors Shouldn't Be Surprised By Zynex, Inc.'s (NASDAQ:ZYXI) P/E

Jan 24
Why Investors Shouldn't Be Surprised By Zynex, Inc.'s (NASDAQ:ZYXI) P/E

Is Zynex (NASDAQ:ZYXI) Using Too Much Debt?

Aug 03
Is Zynex (NASDAQ:ZYXI) Using Too Much Debt?

Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 43%?

Mar 30
Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 43%?

Should You Be Adding Zynex (NASDAQ:ZYXI) To Your Watchlist Today?

Jan 23
Should You Be Adding Zynex (NASDAQ:ZYXI) To Your Watchlist Today?

Short Squeeze Candidate With Low PEG Ratio: Zynex

Oct 05

Zynex begins enrollment in blood loss detection trial for CM-1600 monitoring system

Sep 21

These 4 Measures Indicate That Zynex (NASDAQ:ZYXI) Is Using Debt Safely

Aug 02
These 4 Measures Indicate That Zynex (NASDAQ:ZYXI) Is Using Debt Safely

Zynex Cures The Pain Of Its Shareholders: Q2 Results

Aug 01

Zynex: Upside Looks Well Priced In, Efficiency Headwinds Remain

Jul 25

Is Zynex, Inc. (NASDAQ:ZYXI) Trading At A 46% Discount?

Jul 12
Is Zynex, Inc. (NASDAQ:ZYXI) Trading At A 46% Discount?

Zynex June and Q2 orders hit all-time high, re-affirms Q2 and FY22 guidance

Jul 11

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:ZYXI - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202629026N/A272
12/31/202524015N/A253
12/31/20242006N/A123
9/30/202419451616N/A
6/30/202419461718N/A
3/31/202418981718N/A
12/31/2023184101718N/A
9/30/2023186161616N/A
6/30/2023177171415N/A
3/31/2023169171314N/A
12/31/2022158171314N/A
9/30/2022150181617N/A
6/30/2022143201213N/A
3/31/2022137191414N/A
12/31/20211301767N/A
9/30/202111610-3-2N/A
6/30/20211015-7-7N/A
3/31/2021895-6-5N/A
12/31/202080901N/A
9/30/2020691045N/A
6/30/2020601177N/A
3/31/2020521055N/A
12/31/201945966N/A
9/30/201941977N/A
6/30/2019371088N/A
3/31/20193410910N/A
12/31/2018321089N/A
9/30/20183110910N/A
6/30/20182910N/A10N/A
3/31/2018279N/A9N/A
12/31/2017237N/A8N/A
9/30/2017184N/A5N/A
6/30/2017153N/A3N/A
3/31/2017131N/A1N/A
12/31/2016130N/A2N/A
9/30/201613-1N/A1N/A
6/30/201612-2N/A1N/A
3/31/201612-2N/A1N/A
12/31/201512-3N/A0N/A
9/30/201511-1N/A0N/A
6/30/201513-1N/A0N/A
3/31/201511-6N/A1N/A
12/31/201411-6N/A1N/A
9/30/201412-11N/A1N/A
6/30/201413-12N/A1N/A
3/31/201417-8N/A1N/A
12/31/201322-7N/A0N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ZYXI's forecast earnings growth (45.8% per year) is above the savings rate (2.5%).

Ertrag vs. Markt: ZYXI's earnings (45.8% per year) are forecast to grow faster than the US market (15.4% per year).

Hohe Wachstumserträge: ZYXI's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: ZYXI's revenue (17.5% per year) is forecast to grow faster than the US market (8.9% per year).

Hohe Wachstumseinnahmen: ZYXI's revenue (17.5% per year) is forecast to grow slower than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Insufficient data to determine if ZYXI's Return on Equity is forecast to be high in 3 years time

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y